查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球颈椎间盘置换器械市场
市场调查报告书
商品编码
1176558

2023-2030 年全球颈椎间盘置换器械市场

Global Cervical Total Disc Replacement Device Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内 (2022-2029)，颈椎间盘置换装置的市场规模以 20.9% 的复合年增长率增长。

颈椎间盘置换 (CTDR) 设备是一种治疗患有退行性椎间盘疾病 (DDD) 的患者的设备。 颈部疼痛是颈椎区域 DDD 发展的主要原因。 颈椎间盘置换术通过手术切除退化的椎间盘并将人造椎间盘植入椎骨来治疗 DDD。 该手术是微创手术，术后恢復更快，住院时间更短，再次手术率更低。

市场动态

颈椎人工椎间盘置换装置的全球市场受到颈椎病例数量增加、技术进步、老年人口迅速增加、研发活动增加以改善设备质量和医疗费用飙升。据认为，

增加颈椎间盘置换装置的益处推动市场增长

在预测期内，不断增长的老年人口和医疗设备的技术进步将推动市场增长。 根据 2020 年发表在 Spine Journal 上的一篇文章，颈椎间盘置换术 (CDR) 是一种用于治疗退行性疾病的运动保留手术。 CDR 的基本原理是在减轻疼痛的同时保持颈部活动度，从而降低邻近节段疾病的风险。 多项体外研究报告称，使用运动保持植入物可降低相邻椎间盘的椎间盘压力。

此外，当前的颈椎间盘置换术 (TDR) 设计使用多种生物材料，包括聚乙烯、不銹钢、钛和钴铬 (CoCr)。 最重要的是，这些材料被用作允许在椎间盘空间中进行关节连接的支承面。 植入材料的长期生物学效应包括磨损碎片、宿主炎症免疫反应和导致植入失败的骨质溶解。

市场参与者提供颈椎间盘置换装置。 人造椎间盘，例如 Medtronic 的 Prestige LP 颈椎椎间盘，放置在两个相邻的颈椎之间，以替代患病的颈椎间盘。 这种人造椎间盘旨在保持两个相邻颈椎之间的距离。 两个 Prestige LP 颈椎间盘替换两个相邻的需要手术的患病颈椎间盘。

与颈椎间盘置换相关的风险阻碍了市场增长

但是，颈椎间盘插入重要的神经和血管附近。 医疗保健专业人员仔细定位并保护这些神经和血管，但它们可能会在手术过程中受损。 即使是血管上的一个小伤口也会流血甚至死亡。 神经损伤会导致长期丧失运动能力（瘫痪）和感觉。

COVID-19 影响分析

COVID-19 的出现对全球颈椎间盘置换器械市场产生了重大影响。 根据 2022 年 7 月发表在 World Neurosurgery 上的一篇文章，2020 年第二季度择期手术急剧下降。 在大流行期间接受手术的患者并发症负担高，合併发病率和死亡率增加。 美国和世界各地的患者和脊柱外科医生都感受到了停止择期脊柱手术的影响。

从外科医生的角度来看，预计积压的病例估计需要长达 16 个月的时间才能恢復。 在大流行的前两个月，腰椎择期手术减少了 90%。 远程医疗占脊柱门诊预约的三分之二。 鑑于颈椎和腰椎融合手术的数量持续增加，美国取消选择性脊柱手术的经济影响也很明显。 这些手术是美国最昂贵的手术之一。

内容

第 1 章市场研究方法和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 降低治疗成本
      • 扩大保险范围
    • 约束因素
      • 监管机构延迟批准
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章（按光盘类型）

  • 金属对金属
  • 生物聚合物上的金属

第八章材料

  • 钴铬
  • 钛
  • 不銹钢

第9章适应症

  • 桡神经障碍
  • 椎板切除术
  • 脊髓病
  • 其他

第 10 章最终用户

  • 医院
  • 门诊手术中心
  • 骨科和外伤中心

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 按类型划分的基准

第13章公司简介

  • Zimmer Biomet Holdings
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Medtronic Plc
  • Depuy Synthes
  • NuVasive Inc
  • Centinel Spine, Inc.
  • Ranier Technology Limited
  • Stryker Corporation
  • AxioMed LLC
  • Orthofix International
  • Globus Medical Inc.

第14章 DataM

简介目录
Product Code: DMMD1128

Market Overview

Cervical Total Disc Replacement Device Market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 20.9% during the forecast period (2022-2029).

Cervical Total Disc Replacement (CTDR) device treats patients suffering from Degenerative Disc Disorders (DDD). Neck pain is the major cause of the development of DDD in the cervical spine region. Cervical disc replacement surgery is performed to treat DDD, where the degenerated disc is withdrawn surgically, and an artificial disc is implanted in the vertebra. This is a Minimal Invasive Surgery and results in quick recovery post-surgery, short hospital stays, and a downward revision surgery rate.

Market Dynamics

The global cervical total disc replacement device market is driven by increasing cases of cervical DDD, technological advancements, surge in geriatric population, increasing research and development activities to inprove the quality of device and rising healthcare expanditure.

Increasing benefits of cervical disc replacement devices drive market growth

The growing geriatric population and technological advancements in medical devices drive the market in the forecast period. As per the article published in Spine Journal in 2020, cervical disc replacement (CDR) is a motion-preserving surgical procedure for treating degenerative disorders. The rationale of CDR is to maintain cervical mobility while relieving pain, thereby reducing the risk of adjacent segment disease. Multiple in vitro studies have reported reduced intradiscal pressures in the adjacent level discs when using motion-preserving implants.

Furthermore, current cervical total disc replacement (TDR) designs incorporate various biomaterials, including polyethylene, stainless steel, titanium, and cobalt-chrome (CoCr). These materials are most important in their utilization as bearing surfaces, allowing for articular motion at the disc space. Long-term biological effects of implanted materials include wearing debris, host inflammatory immune reactions, and osteolysis resulting in implant failure.

The market players are offering cervical disc replacement devices. For instance, an artificial disc, such as the Prestige LP cervical disc produced by Medtronic, is placed between two adjacent cervical vertebrae to replace a diseased cervical disc. It is designed to maintain the distance between two adjacent cervical vertebrae. Two Prestige LP cervical discs replace two diseased cervical discs that are next to each other and require surgery.

The risk associated with cervical total disc replacement surgery will hamper the growth of the market

However, the cervical disc is inserted near important nerves and blood vessels. Healthcare professionals carefully find and protect these nerves and blood vessels, but there is a chance of injury to nerves or blood vessels at the time of the surgery. A little cut to a blood vessel can produce hemorrhage or even death. Injury to a nerve can cause long-term loss of movement (paralysis) or feeling.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global cervical total disc replacement device market. As per the article published in World Neurosurgery in July 2022, Elective surgery declined drastically during the second quarter of 2020. Patients undergoing surgery during the pandemic had a higher comorbidity burden, increasing total complication and mortality rates. The ramifications of canceling elective spine surgery were felt by both patients and spine surgeons in the U.S. and worldwide.

From a surgeon's perspective, the projected backlog of cases was estimated to take as long as 16 months to recover. Elective lumbar spine procedures decreased by 90% in the first two months of the pandemic. Telemedicine comprises two-thirds of outpatient spine appointments. The economic effect of canceling elective sp U.S9 ine surgery was also noticeable, given that cervical and lumbar fusion procedural volumes are consistently rising. These procedures rank among some of the most costly surgeries in the United States.

Segment Analysis

The radiculopathy segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The radiculopathy segment accounts for the largest market share. Cervical total disc replacement is a routinely used treatment for radiculopathy due to degenerative disease of the cervical spine. The procedure originated to avoid complications seen with the traditional anterior cervical discectomy and fusion.

Cervical radiculopathy is a frequently encountered neurologic condition most often caused by encroachment of a cervical nerve root. It typically presents with neck and arm pain and sometimes sensory loss or loss of motor function in the affected nerve root distribution. The most common cause of cervical radiculopathy is degenerative features, including reduced disc height, osteophyte formation, and disc herniation.

Anterior cervical discectomy and fusion, either as individual implant surgical therapy or with further plating, has been the standard criterion for cervical radiculopathy for decades, and more than 100,000 patients receive this treatment in the US annually. Surgical treatment for cervical radiculopathy is growing in most countries and is projected to rise by more than 10% in the next 20 years.

Geographical Analysis

North America region holds the largest market share of the global cervical total disc replacement device market

North America dominates the cervical total disc replacement device market and is expected to show a parallel trend over the forecast period. The market is driven in the North American region by the increasing geriatric population, active key players, and product launches.

The key players apply market strategies such as acquisition and product launches to expand the business. For instance, in February 2021, NuVasive acquired Simplify Medical, which develops the Simplify Cervical Artificial Disc for cervical total disc replacement (cTDR), valued at $150m. With the acquisition, NuVasive can address all key parts of the cervical spine by providing inclusive, procedurally integrated solutions across anterior cervical discectomy and fusion (ACDF), posterior cervical fusion (PCF), and cTDR procedures.

Also, in April 2021, NuVasive, Inc. announced that the NuVasive Simplify Cervical Artificial Disc (Simplify Disc) received approval from the U.S. Food and Drug Administration for two-level cervical total disc replacement (cTDR). In a two-level FDA Investigational Device Exemption study, the Simplify Disc demonstrated clinical superiority at 24 months compared to anterior cervical discectomy and fusion (ACDF).

Competitive Landscape

The cervical total disc replacement device market is a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are Zimmer Biomet Holdings, Medtronic Plc, Depuy Synthes, NuVasive Inc, Centinel Spine, Inc., Ranier Technology Limited, Stryker Corporation, AxioMed LLC, Orthofix International, Globus Medical Inc., among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the cervical total disc replacement device market globally.

For instance,

In August 2021, Orthofix Medical launched the M6-C artificial cervical disc compared to anterior cervical discectomy and fusion for the therapy of contiguous two-level symptomatic cervical radiculopathy in the United States.

Zimmer Biomet Holdings

Overview:

Zimmer Biomet is a medical device company founded in 1927 to produce aluminum splints. The headquartered is in Warsaw, Indiana. Zimmer Biomet delivers personalized strategy and tailored solutions so you can manage the pain.

Product Portfolio:

Mobi-C Cervical Disc: The Mobi-C Cervical Disc is developed for cervical disc replacement to repair segmental motion and disc height. The components of Mobi-C include superior and inferior cobalt chromium molybdenum alloy endplates coated with plasma-sprayed titanium and hydroxyapatite coating and a polyethylene mobile bearing insert.

The global cervical total disc replacement device market report would provide access to approximately 60+ market data tables, 60+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Lower cost of treatment
      • 4.1.1.2. Increase in the insurance coverage for the devices
    • 4.1.2. Restraints:
      • 4.1.2.1. Slow regulatory Approvals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Disc Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disc Type
    • 7.1.2. Market Attractiveness Index, By Disc Type
  • 7.2. Metal on Metal*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Metal on Biopolymer

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 8.1.2. Market Attractiveness Index, By Material
  • 8.2. Cobalt-Chromium*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Titanium
  • 8.4. Stainless Steel

9. By Indication

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 9.1.2. Market Attractiveness Index, By Indication
  • 9.2. Radiculopathy*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Laminectomy
  • 9.4. Myelopathy
  • 9.5. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Orthopedic and Trauma Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disc Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disc Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disc Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disc Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disc Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Type Benchmarking

13. Company Profiles

  • 13.1. Zimmer Biomet Holdings*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Medtronic Plc
  • 13.3. Depuy Synthes
  • 13.4. NuVasive Inc
  • 13.5. Centinel Spine, Inc.
  • 13.6. Ranier Technology Limited
  • 13.7. Stryker Corporation
  • 13.8. AxioMed LLC
  • 13.9. Orthofix International
  • 13.10. Globus Medical Inc.

LIST NOT EXHAUSTIVE

14. Global Cervical Total Disc Replacement Device Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us